摘要
匹伐他汀是新一代他汀类药物。该药不仅具有较强的HMG-CoA还原酶抑制作用,而且呈肝细胞选择性,药动学性质优异,安全性好,已被制药界誉为是“超级他汀”。现就匹伐他汀的药理及临床应用进行综述。
Pitavastatin is the most recently approved statin. It not only competitively inhibits HMG-CoA reductase,but also has liver-selective action, thus being regarded as 'superstatins'. This paper reviews pharmacology and pharmacotherapy of pitavastatin.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2005年第4期483-487,共5页
Chinese Journal of New Drugs